Replies to post #232488 on Biotech Values

[DewDiligence]

NTRP reverse-merger into Metuchen Pharmaceuticals revised to give existing NTRP shareholders a 49% equity stake:

https://www.prnewswire.com/news-releases/neurotrope-shareholders-to-own-49-percent-of-petros-under-revised-merger-agreement-with-metuchen-301141972.html